We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Technion Researchers Succeed in Creating in the Lab Beating Heart Tissue from Embryonic Stem Cells

Read time: 1 minute

Technion researchers from the Faculty of Bio-Medical Engineering and the Rappaport Faculty of Medicine have succeeded in creating in the laboratory beating heart tissue from human embryonic stem cells.

Moreover they have succeeded in creating blood vessels in the tissue, which will enable its acceptance by the heart muscle.

The researchers are Dr. Shulamit Levenberg and Prof. Lior Gepstein. They were joined by doctoral student Oren Caspi and master student Ayelet Lesman.

The scientific journal Circulation Research reports in its on-line issue on two innovations in the researchers’ work: one, the use of human embryonic stem cells, and two, the creation of a vascular system in the tissue, which is critical for its acceptance by the body.

“Without this system, acceptance could be prolonged and the cells could die during this time period,” explains Dr. Levenberg.

“In our work, we demonstrated the importance of the endothelial cells (cells that build blood vessels), which encourage differentiation of the heart cells and their organization, in addition to their multiplication. That is – it is important to create heart cell tissue, with all its component cells, in this case the endothelial cells, heart cells and cells that support the blood vessels.”

The Technion researchers created the heart tissue in the laboratory by differentiating human embryonic stem cells into heart muscle cells and endothelial cells and growing them together with embryonic supporting cells (fibroblasts). The growth was done in three dimensions on a porous, biodegradable scaffold that the Technion researchers also created in their laboratory.

In the future, they will examine the possibility of implanting the tissue in a heart, in order to see if the blood vessels in the engineered tissue will improve acceptance of the new tissue and its connection to the vascular system.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.